Nanobiotix Reports Q4 2025 Earnings: Full-Year 2025 Financial Results and Operational Updates

miércoles, 1 de abril de 2026, 2:04 pm ET1 min de lectura
NBTX--

Nanobiotix S.A. (NBTX) reported full year 2025 financial and operational results, with CEO Laurent Levy and CFO Bart Van Rhijn participating in the conference call. The company's research and clinical development programs are ongoing, with regulatory developments and financial performance also being discussed. The call is being webcast and will be available for replay on Nanobiotix's website.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios